<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An Epstein-Barr virus (EBV)-producer line, designated Akata, was established from a Japanese patient with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The Akata line possessed the Burkitt's-type chromosome translocation, t(8q- ; 14q+), and was derived from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell </plain></SENT>
<SENT sid="2" pm="."><plain>Akata cells produced a large quantity of transforming virus upon treatment of cells with anti-immunoglobulin antibodies (Takada, 1984) </plain></SENT>
<SENT sid="3" pm="."><plain>Southern blot analysis of <z:mp ids='MP_0001799'>viral</z:mp> DNA indicated that the Akata EBV is nondefective and more representative of <z:mp ids='MP_0002169'>wild-type</z:mp> viruses </plain></SENT>
<SENT sid="4" pm="."><plain>Akata cells should be useful as a source of EBV </plain></SENT>
</text></document>